NATHBIOGEN.NSNATHBIOGEN.NS
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +42.65% | +16.18% | +20.75% | +16.33% | +36.21% |
| Gross Profit Growth | -45.63% | +38.57% | -21.97% | +26.88% | +54.22% |
| EBITDA Growth | -11.35% | +49.83% | -1.47% | +9.23% | +106.65% |
| Operating Income Growth | -17.18% | +47.61% | +0.00% | +4.48% | +28.30% |
| Net Income Growth | -45.26% | -30.61% | +32.39% | +11.77% | +332.65% |
| EPS Growth | -50.47% | +92.75% | -48.86% | +5.41% | +164.15% |
| EPS Diluted Growth | -50.47% | +92.75% | -43.18% | +5.41% | +164.15% |
| Weighted Average Shares Growth | +10.53% | +4.87% | +7.62% | +0.19% | -6.38% |
| Weighted Average Shares Diluted Growth | +10.53% | +4.87% | +0.85% | +0.19% | -6.38% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -100.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -100.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -32.57% | +0.00% | -5.73% | +0.00% | +54.96% |
| Inventory Growth | +2.72% | +0.00% | +46.77% | +0.00% | +84.25% |
| Asset Growth | -2.16% | +0.00% | +16.58% | +0.00% | +22.41% |
| Book Value per Share Growth | -4.10% | +1.09% | -1.83% | +5.45% | +13.41% |
| Debt Growth | +13.02% | +0.00% | +11.02% | +0.00% | +21.43% |
| R&D Expense Growth | +0.00% | +0.00% | -100.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +98.96% | -67.78% | -57.13% | +11.60% | +56.62% |